Anixa Biosciences (ANIX) Stock Statistics & Valuation Metrics

Anixa Biosciences has a market cap or net worth of $110.48M. The enterprise value is $133.00M.

Anixa Biosciences has 33,376,690 shares outstanding. The number of shares has decreased by -2.65% in one year.

Anixa Biosciences’s return on equity (ROE) is -0.72 and return on invested capital (ROIC) is -82.67%.

The current PE Ratio of Anixa Biosciences is ―. Anixa Biosciences’s PEG ratio is 0.96.

In the last 12 months, Anixa Biosciences had revenue of 0.00 and earned -10.93M in profits. Earnings per share was -0.34.

In the last 12 months, operating cash flow was -7.17M and capital expenditures 0.00, giving a free cash flow of -7.17M billion.

Anixa Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―

Anixa Biosciences upcoming earnings date is Mar 8, 2024, TBA (Confirmed).

Anixa Biosciences as a current ratio of 8.08, with Debt / Equity ratio of 1.35%

In the past 12 months, Anixa Biosciences has paid 0.00 in taxes.

Anixa Biosciences EV to EBITDA ratio is -11.37, with an EV/FCF ratio of -18.54.

Anixa Biosciences has $15.17M in cash and marketable securities with $204.00K in debt, giving a net cash position of $14.97M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Anixa Biosciences is $14.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy